Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' reply.
Domains
Santé publique et épidémiologie| Origin | Files produced by the author(s) |
|---|
Journal Articles
Alimentary Pharmacology & Therapeutics (Suppl)
Year : 2021
Gestionnaire HAL 3 Sorbonne Université : Connect in order to contact the contributor
https://hal.sorbonne-universite.fr/hal-03777108
Submitted on : Wednesday, September 14, 2022-12:54:44 PM
Last modification on : Thursday, December 14, 2023-1:50:37 PM
Long-term archiving on: Thursday, December 15, 2022-7:02:06 PM
Dates and versions
Identifiers
- HAL Id : hal-03777108 , version 1
- DOI : 10.1111/apt.16340
- PUBMED : 33831235
Cite
Stanislas Pol, Clovis Lusivika Nzinga, Fabrice Carrat. Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' reply.. Alimentary Pharmacology & Therapeutics (Suppl), 2021, 53 (9), pp.1050. ⟨10.1111/apt.16340⟩. ⟨hal-03777108⟩
Collections
99
View
16
Download